These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28623237)

  • 1. NICE approves trastuzumab emtansine after deal with drug company.
    Kmietowicz Z
    BMJ; 2017 Jun; 357():j2930. PubMed ID: 28623237
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE recommends routine NHS funding for Kadcyla.
    Venkatesa P
    Lancet Oncol; 2017 Aug; 18(8):e435. PubMed ID: 28648556
    [No Abstract]   [Full Text] [Related]  

  • 3. Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?
    Ricci F; Le Tourneau C
    Chin Clin Oncol; 2018 Feb; 7(1):3. PubMed ID: 29156892
    [No Abstract]   [Full Text] [Related]  

  • 4. Trastuzumab emtansine for HER2-positive breast cancer.
    Venkatesan P
    Lancet Oncol; 2016 Dec; 17(12):e528. PubMed ID: 27866859
    [No Abstract]   [Full Text] [Related]  

  • 5. Trastuzumab emtansine and cost-based decision making.
    The Lancet
    Lancet; 2017 Jan; 389(10064):2. PubMed ID: 28091366
    [No Abstract]   [Full Text] [Related]  

  • 6. Trastuzumab-emtansine might affect the survival outcome by reversing increased platelet-to-lymphocyte ratio in HER2-positive metastatic breast cancer patients.
    Altundag K
    J BUON; 2019; 24(1):407. PubMed ID: 30942001
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment.
    Ruiz-Rivero J; Horcajada-Reales C; Tardío JC; Borbujo-Martínez JM
    An Bras Dermatol; 2018; 93(6):938-939. PubMed ID: 30484553
    [No Abstract]   [Full Text] [Related]  

  • 8. Corneal Changes in Trastuzumab Emtansine Treatment.
    Kreps EO; Derveaux T; Denys H
    Clin Breast Cancer; 2018 Aug; 18(4):e427-e429. PubMed ID: 29615304
    [No Abstract]   [Full Text] [Related]  

  • 9. NICE rejects trastuzumab emtansine for use on NHS.
    Kmietowicz Z
    BMJ; 2015 Dec; 351():h6837. PubMed ID: 26673454
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on antibody-drug conjugates in breast cancer.
    Hugo HS
    Clin Adv Hematol Oncol; 2021 Mar; 19(3):148-151. PubMed ID: 33739962
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates.
    Kolodych S; Michel C; Delacroix S; Koniev O; Ehkirch A; Eberova J; Cianférani S; Renoux B; Krezel W; Poinot P; Muller CD; Papot S; Wagner A
    Eur J Med Chem; 2017 Dec; 142():376-382. PubMed ID: 28818506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pfizer makes breast cancer drug free while NICE decides its future.
    Kmietowicz Z
    BMJ; 2017 May; 357():j2225. PubMed ID: 28483771
    [No Abstract]   [Full Text] [Related]  

  • 13. Can cancer clinical trials be fixed?
    Allison M
    Nat Biotechnol; 2011 Jan; 29(1):13-5. PubMed ID: 21221090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].
    Guerin M; Sabatier R; Gonçalves A
    Bull Cancer; 2015 Apr; 102(4):390-7. PubMed ID: 25790739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NICE confirms advanced breast cancer drug is too expensive for NHS.
    White C
    BMJ; 2014 Aug; 349():g5078. PubMed ID: 25106642
    [No Abstract]   [Full Text] [Related]  

  • 16. On more work for NICE.
    Stevens S
    Health Serv J; 2005 Oct; 115(5978):17. PubMed ID: 16273884
    [No Abstract]   [Full Text] [Related]  

  • 17. Ado-trastuzumab emtansine (Kadcyla) for HER2-positive metastatic breast cancer.
    Med Lett Drugs Ther; 2013 Sep; 55(1425):75-6. PubMed ID: 24662957
    [No Abstract]   [Full Text] [Related]  

  • 18. Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges?
    Kubizek F; Eggenreich B; Spadiut O
    Protein Pept Lett; 2017; 24(8):686-695. PubMed ID: 28741467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pfizer to make palbociclib temporarily free on NHS.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e309. PubMed ID: 28506556
    [No Abstract]   [Full Text] [Related]  

  • 20. Never too old to fight breast cancer: A case report.
    Zuradelli M; Masci G; Ferraro E; Losurdo A; De Sanctis R; Torrisi R; Santoro A
    Medicine (Baltimore); 2018 Mar; 97(9):e9981. PubMed ID: 29489698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.